HSKA logo

Heska Stock Price

Symbol: NasdaqCM:HSKAMarket Cap: US$1.3bCategory: Healthcare

HSKA Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

HSKA Community Narratives

There are no narratives available yet.

Recent HSKA News & Updates

No updates

Heska Corporation Key Details

US$254.9m

Revenue

US$145.5m

Cost of Revenue

US$109.4m

Gross Profit

US$129.4m

Other Expenses

-US$20.0m

Earnings

Last Reported Earnings
Mar 31, 2023
Next Reporting Earnings
n/a
Earnings per share (EPS)
-1.84
Gross Margin
42.93%
Net Profit Margin
-7.86%
Debt/Equity Ratio
22.9%

Heska Corporation Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About HSKA

Founded
1988
Employees
808
CEO
Kevin Wilson
WebsiteView website
www.heska.com

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.

U.S. Market Performance

  • 7 Days: -0.2%
  • 3 Months: 12.2%
  • 1 Year: 22.4%
  • Year to Date: 7.7%
The Communication Services sector gained 3.4% while the market remained flat over the last week. As for the longer term, the market has risen 22% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading